Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Allison Hagerman

Vp, Product Development at Oncolytics Biotech Inc (ONCY)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$3K
Total bought / sold$8K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Feb 13SEC ONCYOncolytics Biotech Inc Buy 10,000115,059 held (+10%) $0.83 $8K -32.5%
  • Buy

    Vp, Product Development Allison Hagerman bought $8K of ONCY at $0.83 — first open-market purchase in our records.